ZEVRA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Zevra Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Zevra Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 53.2M shares, a 47% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 53.2M +17M +47% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 42M +8.06M +23.8% Jun 30, 2024 10-Q 2024-11-13
Q1 2024 41.9M +7.97M +23.5% Mar 31, 2024 10-Q 2024-11-13
Q4 2023 41.5M +6.99M +20.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 36.2M +1.71M +4.96% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 33.9M -561K -1.63% Jun 30, 2023 10-Q 2023-11-07
Q1 2023 33.9M -542K -1.57% Mar 31, 2023 10-Q 2023-11-07
Q4 2022 34.5M -465K -1.33% Dec 31, 2022 10-K 2024-04-01
Q3 2022 34.5M -816K -2.31% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 34.5M -489K -1.4% Jun 30, 2022 10-Q 2022-11-10
Q1 2022 34.4M +5.94M +20.9% Mar 31, 2022 10-Q 2022-11-10
Q4 2021 35M +30.5M +672% Dec 31, 2021 10-K 2024-04-01
Q3 2021 35.3M -37.2M -51.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 35M -32.2M -48% Jun 30, 2021 10-Q 2021-11-10
Q1 2021 28.5M -28.3M -49.8% Mar 31, 2021 10-Q 2021-11-10
Q4 2020 4.54M +2.27M +99.7% Dec 31, 2020 10-K 2023-03-07
Q3 2020 72.5M +40.1M +124% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 67.2M +38.4M +133% Jun 30, 2020 10-Q 2020-10-30
Q1 2020 56.8M +28.8M +103% Mar 31, 2020 10-Q 2020-10-30
Q4 2019 2.27M +618K +37.4% Dec 31, 2019 10-K 2022-03-31
Q3 2019 32.4M +16.3M +102% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 28.9M +13M +81.4% Jun 30, 2019 10-Q 2019-11-14
Q1 2019 28M +12.9M +85.2% Mar 31, 2019 10-Q 2019-11-14
Q4 2018 1.65M -13M -88.7% Dec 31, 2018 10-K 2021-03-12
Q3 2018 16M +1.38M +9.45% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 15.9M +1.25M +8.51% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 15.1M +458K +3.13% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 14.7M +10.4K +0.07% Dec 31, 2017 10-K 2020-02-28
Q3 2017 14.7M +10.4K +0.07% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 14.7M +10.4K +0.07% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 14.6M +148K +1.02% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 14.6M +156K +1.08% Dec 31, 2016 10-K 2019-03-01
Q3 2016 14.6M +405K +2.85% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 14.6M +419K +2.94% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 14.5M +12.1M +506% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 14.5M +12.1M +509% Dec 31, 2015 10-K 2018-03-30
Q3 2015 14.2M Sep 30, 2015 10-Q 2015-11-13
Q2 2015 14.2M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 2.39M Mar 31, 2015 10-Q 2015-05-29
Q4 2014 2.38M 0 0% Dec 31, 2014 10-K 2018-03-30
Q4 2013 2.38M Dec 31, 2013 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.